1. Home
  2. RAPP vs EVV Comparison

RAPP vs EVV Comparison

Compare RAPP & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$37.74

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo Eaton Vance Limited Duration Income Fund of Beneficial Interest

EVV

Eaton Vance Limited Duration Income Fund of Beneficial Interest

HOLD

Current Price

$9.51

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
EVV
Founded
2022
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2024
2003

Fundamental Metrics

Financial Performance
Metric
RAPP
EVV
Price
$37.74
$9.51
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$48.50
N/A
AVG Volume (30 Days)
329.7K
298.2K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
24.34
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$8.97
52 Week High
$42.27
$10.41

Technical Indicators

Market Signals
Indicator
RAPP
EVV
Relative Strength Index (RSI) 58.97 51.68
Support Level $25.48 $9.38
Resistance Level $41.59 $9.57
Average True Range (ATR) 2.15 0.11
MACD 0.07 0.01
Stochastic Oscillator 61.14 25.83

Price Performance

Historical Comparison
RAPP
EVV

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.

Share on Social Networks: